- Latest week
- 10 Jul 2026
- Close
- 1961.500000
- Fair value
- 1600.391582
- Next-week expectancy
- Positive 55.83%
GSK Chart Pack
GSK plc
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, GSK fell 2.89%, moving from 2,019.82 to 1,961.50. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 2.78 and has softened across the 12-week window. Market Dynamics is -0.33 on the latest week. Next-week expectancy is positive at 55.83% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 1,961.50
- 12-Week Change
- -2.89%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Positive 55.83%
- Signal Weeks
- 3 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- 2.78
- Market Dynamics
- -0.33
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 1,961.50
- 12-Week Change
- -2.89%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Positive 55.83%
- Signal Weeks
- 3 of 12
- Vs Trend Line
- Below
- Vs Fair Value
- Above
- Relative Strength
- 2.78
- Market Dynamics
- -0.33
Over the latest 12 completed weeks ending 2026-07-10, GSK fell 2.89%, moving from 2,019.82 to 1,961.50. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 2.78 and has softened across the 12-week window. Market Dynamics is -0.33 on the latest week. Next-week expectancy is positive at 55.83% based on similar historical setup states.
Industry Peers
United Kingdom equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| AZN AstraZeneca PLC | LSE | 10 Jul 2026 | 14500.00 | 14526.00 | 12388.00 | 12834.00 | -11.49% |